Seil Kim

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
CD1d-restricted invariant NKT (iNKT) cells are a group of innate-like regulatory T cells that recognize lipid antigens. Both mouse modeling experiments and human clinical studies have suggested a key role for iNKT cells in anti-HBV immunity and these potent T cells can be explored as a novel therapeutic target for anti-HBV treatment. We aim to humanize mice(More)
Immunostimulatory interventions represent one of a limited number of options for the treatment of incurable tumors and metastases after the failure of conventional surgical, chemotherapeutic, and radiological procedures. CD1d-restricted natural killer T (NKT) cells are an unconventional subset of T cells that co-express a T-cell receptor (TCR) and typical(More)
  • 1